Gastrointestinal

Futapan Tablets
  • Active Substance (s) : Pantoprazole 40 mg
  • Dosage Form : Enteric Coated Tablets
  • Pack : 14 tablets/blister
  • Indication :
    • Reflux oesophagitis
    • Eradication of Helicobacter pylori (H
    • pylori) in combination with appropriate antibiotic therapy in patients with H
    • pylori-associated ulcers
    • Gastric and duodenal ulcer
    • Zollinger-Ellison-Syndrome and other pathological hypersecretory conditions
  • Product Description : Futapan is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells. Futapan is converted to its active form in the acidic environment in the parietal cells where it inhibits the H+, K+-ATPase enzyme, i.e. the final stage in the production of hydrochloric acid in the stomach
  • Recommended Daily Dosage :
    • One tablet of per day